Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the antibiotics market grown in recent years?

In recent years, the size of the antibiotics market has shown significant growth. The market value is set to rise from $84.68 billion in 2024 to $89.31 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.5%. The growth observed in the historical period is ascribed to the heightened occurrence of infectious diseases, an expanding global population and urbanization, enhanced healthcare awareness, accessibility of healthcare services, and the prevalence of antibiotic-resistant strains.

How is the antibiotics market size expected to evolve during the forecast period?

In the upcoming years, the antibiotics market is projected to witness robust growth, reaching a market value of $110.65 billion by 2029, with a compound annual growth rate (CAGR) of 5.5%. This surging growth during the predicted period is linked to factors such as global health threats, increased healthcare spending, government policies and regulations, coupled with augmented international collaboration. The forecast period also anticipates significant trends including the progression of oral antibiotics, collaborations and partnerships aimed at antibiotic development, regulatory incentives and pathways, stewardship programs for antimicrobial usage in healthcare settings, and global health initiatives to enhance accessibility to antibiotics.

Get your antibiotics market report here!

https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report

Which key drivers are propelling the antibiotics market’s growth?

The growing occurrence of bacterial infections is likely to propel the antibiotics market in the future. Bacterial infections are diseases incited by bacteria, which are microorganism made up of a single cell. Antibiotics play a crucial role in curbing and averting bacterial illnesses as they inhibit bacterial proliferation. To illustrate, the World Health Organization, a specialized health agency of the United States based in Switzerland, reported in February 2023 that 30 countries across the globe experienced a cholera outbreak in 2022. The cholera case fatality ratio (CFR) stood at 1.9% in 2021, marking the highest rate in ten years. Consequently, the escalating incidence of bacterial infections is fueling the antibiotics market.

What are the market segments in the antibiotics industry?

The antibiotics market covered in this report is segmented –

1) By Drug Class: Penicillin, Cephalosporin, Aminoglycosides, Tetracycline, Macrolides, Fluoroquinolones, Sulfonamides, Other Classes

2) By Spectrum Of Activity: Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic

3) By Route Of Administration: Oral, Intravenous, Other Routes

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By Application: Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infections, Gastrointestinal Infections, Other Applications

Subsegments:

1) By Penicillin: Natural Penicillins, Aminopenicillins, Penicillinase-resistant Penicillins, Extended-spectrum Penicillins

2) By Cephalosporin: First-generation, Second-generation, Third-generation, Fourth-generation, Fifth-generation

3) By Aminoglycosides: Gentamicin, Tobramycin, Amikacin, Neomycin

4) By Tetracycline: Tetracycline, Doxycycline, Minocycline, Oxytetracycline

5) By Macrolides: Erythromycin, Azithromycin, Clarithromycin

6) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin, Ofloxacin

7) By Sulfonamides: Sulfamethoxazole, Sulfadiazine, Sulfasalazine

8) By Other Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11923&type=smp

Which leading companies are shaping the growth of the antibiotics market?

Major companies operating in the antibiotics market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb (BMS), AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim, Viatris Inc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company, Sun Pharmaceutical Industries Limited, Cipla Ltd., Ferring Pharmaceuticals, Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Limited, Basilea Pharmaceutica Ltd., Paratek Pharmaceuticals Inc., Spero Therapeutics Inc., Nabriva Therapeutics Plc

What key trends are currently impacting the antibiotics market’s development?

Obtaining approvals for new products is becoming a leading trend within the antibiotics market. Major players in this sector are earning regulatory endorsements for their innovative antibiotic creations. For example, Alkem Laboratories Ltd, a pharmaceutical entity based out of India, initiated the launch of a product named Zidavi in January 2023. This medication, which combines ceftazidime and avibactam, is designated for therapeutic purposes involving complicated urinary tract infections, intra-abdominal infections, and pneumonia resulting from multi-drug resistant (MDR) Gram-negative bacteria. Zidavi brings substantial progress to the battle against antibiotic resistance, being one of the rare effective antibiotics against MDR Gram-negative bacteria.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11923

Which geographic areas are influencing the growth of the antibiotics market?

North America was the largest region in the antibiotics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Functional Foods Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/functional-foods-global-market-report

Anticoagulants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

Food Encapsulation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/food-encapsulation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: